Theratechnologiesの将来のP / E
Theratechnologiesの将来のP / Eは何ですか。
Theratechnologies, Inc.の将来のP / Eは55.25です。
将来のP / Eの定義は何ですか。
未来比率P / E (株価収益率)は、企業の株価と今後12ヶ月間の1株当たり利益見込額との比率です。
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
TSXのセクタHealth Careにおける将来のP / Eの企業と比べるTheratechnologies
Theratechnologiesは何をしますか。
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Theratechnologiesと類似の将来のp / e
- HCI Incの将来のP / Eは54.77です。
- Atomo Diagnosticsの将来のP / Eは54.95です。
- United Breweriesの将来のP / Eは54.95です。
- Genetic Signaturesの将来のP / Eは54.95です。
- Atomo Diagnosticsの将来のP / Eは54.95です。
- Ondasの将来のP / Eは54.95です。
- Theratechnologiesの将来のP / Eは55.25です。
- Cintasの将来のP / Eは55.55です。
- exactEarthの将来のP / Eは55.56です。
- ICICI Prudential Life Insuranceの将来のP / Eは55.87です。
- Opsensの将来のP / Eは56.18です。
- IQE Plcの将来のP / Eは56.18です。
- XDの将来のP / Eは56.18です。